We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
On an almost party-line vote of 230-192, the Democrats’ drug pricing bill H.R. 3 made its way out of the House on Thursday with an amendment requiring drugmakers to disclose drug prices in their direct-to-consumer advertising.